Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immunocore Holdings (IMCR) Long-Term Deferred Tax (2019 - 2025)

Immunocore Holdings (IMCR) has disclosed Long-Term Deferred Tax for 7 consecutive years, with $14.3 million as the latest value for Q3 2025.

  • Quarterly Long-Term Deferred Tax rose 13.19% to $14.3 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $14.3 million through Sep 2025, up 13.19% year-over-year, with the annual reading at $14.8 million for FY2024, 34.79% up from the prior year.
  • Long-Term Deferred Tax hit $14.3 million in Q3 2025 for Immunocore Holdings, up from $14.1 million in the prior quarter.
  • In the past five years, Long-Term Deferred Tax ranged from a high of $14.8 million in Q4 2024 to a low of $3.5 million in Q4 2021.
  • Historically, Long-Term Deferred Tax has averaged $11.1 million across 5 years, with a median of $11.8 million in 2023.
  • Biggest five-year swings in Long-Term Deferred Tax: skyrocketed 120.64% in 2023 and later increased 13.19% in 2025.
  • Year by year, Long-Term Deferred Tax stood at $3.5 million in 2021, then soared by 43.27% to $5.0 million in 2022, then soared by 120.64% to $11.0 million in 2023, then soared by 34.79% to $14.8 million in 2024, then fell by 3.09% to $14.3 million in 2025.
  • Business Quant data shows Long-Term Deferred Tax for IMCR at $14.3 million in Q3 2025, $14.1 million in Q2 2025, and $14.4 million in Q1 2025.